Federation Des Caisses Desjardins Du Quebec Cytokinetics Inc Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Cytokinetics Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 195 shares of CYTK stock, worth $9,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195
Previous 195
-0.0%
Holding current value
$9,163
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$689 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$553 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$455 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$365 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$303 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.42B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...